Skip To Main Content
Maziar Arfaee on Muck Rack

Maziar Arfaee

As seen in: Nature, Science Magazine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Maziar

Contact Maziar, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Toward developing a compact total artificial heart using a soft robotic fluidic transmission system

|
By Giriraj Lokhande, Mahima Bose, Seung Hyun Jang, Maziar Arfaee
| Science Magazine Verified
Abstract Cardiovascular diseases are a leading cause of mortality, with limited possibilities for transplantation due to a critical shortage of donor hearts. Replacing the heart with total artificial hearts (TAHs) remains challenging, due to size constraints and energy requirements, among others. To address this, we introduce the LIMO heart, a compact TAH concept based on an efficient soft fluidic transmission system.
Open in Who Shared Issue with article?

A soft robotic total artificial hybrid heart - Nature Communications

|
By Maziar Arfaee, Lucrezia Lorenzon, Matteo Cianchetti
| Nature Verified
Abstract End-stage heart failure is a deadly disease. Current total artificial hearts (TAHs) carry high mortality and morbidity and offer low quality of life. To overcome current biocompatibility issues, we propose the concept of a soft robotic, hybrid (pumping power comes from soft robotics, innerlining from the patient’s own cells) TAH.
Open in Who Shared Issue with article?

The ongoing quest for the first total artificial heart as destination therapy - Nature Reviews Cardiology

|
By Jolanda Kluin, Annemijn Vis, Maziar Arfaee
| Nature Verified
Abstract Many patients with end-stage heart disease die because of the scarcity of donor hearts. A total artificial heart (TAH), an implantable machine that replaces the heart, has so far been successfully used in over 1,700 patients as a temporary life-saving technology for bridging to heart transplantation. However, after more than six decades of research on TAHs, a TAH that is suitable for destination therapy is not yet available.
Open in Who Shared Issue with article?
See all 3 articles